Skip navigation

A Big Three Months for Biotech ETFs

Biotech-focused ETFs dominated the list of the 20 top-performing funds over the past three months.

Based on three-month returns. Minimum of $5 million in net assets, excluding leveraged and inverse ETFs.

Data as of 12/2/2019.

 

Aniket Ullal is the founder and CEO of First Bridge Data, a provider of independent ETF data and analytics to institutional clients. Previously he had product management responsibility for S&P’s U.S. indexes, including the widely followed S&P 500 and S&P/Case-Shiller indexes. He is the author of ETF Investment Strategies (McGraw-Hill, 2013).

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish